Trazher 150 mg Powder for Concentrate for Solution for Infusion is approved in Singapore
On 19 Oct 2022, Trazher (Trastuzumab) Powder for Concentrate for Solution for Infusion 150mg/vial is approved by Health Sciences Authority (HSA) of Singapore. The Health Sciences Authority (HSA) is a statutory board under the Ministry of Health of the Government of Singapore. It is a multi-disciplinary agency, responsible for applying medical, pharmaceutical and scientific expertise to protect and advance public health and safety.